Cargando…

Iron as Therapeutic Target in Human Diseases

Detalles Bibliográficos
Autores principales:	Gozzelino, Raffaella, Poli, Maura, Arosio, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958491/ https://www.ncbi.nlm.nih.gov/pubmed/31817314 http://dx.doi.org/10.3390/ph12040178

Ejemplares similares

Iron Homeostasis in Health and Disease
por: Gozzelino, Raffaella, et al.
Publicado: (2016)

The importance of iron in pathophysiologic conditions
por: Gozzelino, Raffaella, et al.
Publicado: (2015)

New Advances in Iron Metabolism, Ferritin and Hepcidin Research
por: Arosio, Paolo
Publicado: (2022)

Iron distribution in different tissues of homozygous Mask (msk/msk) mice and the effects of oral iron treatments
por: Asperti, Michela, et al.
Publicado: (2021)

Analysis of Nucleotide Variations in Genes of Iron Management in Patients of Parkinson's Disease and Other Movement Disorders
por: Castiglioni, Emanuela, et al.
Publicado: (2010)

Hepatic heparan sulfate is a master regulator of hepcidin expression and iron homeostasis in human hepatocytes and mice
por: Poli, Maura, et al.
Publicado: (2019)

The Antitumor Didox Acts as an Iron Chelator in Hepatocellular Carcinoma Cells
por: Asperti, Michela, et al.
Publicado: (2019)

Heparanase Overexpression Reduces Hepcidin Expression, Affects Iron Homeostasis and Alters the Response to Inflammation
por: Asperti, Michela, et al.
Publicado: (2016)

Biochemical, Biophysical and Functional Characterization of an Insoluble Iron Containing Hepcidin–Ferritin Chimeric Monomer Assembled Together with Human Ferritin H/L Chains at Different Molar Ratios
por: Boumaiza, Mohamed, et al.
Publicado: (2021)

Sucrosomial(®) Iron Supplementation in Mice: Effects on Blood Parameters, Hepcidin, and Inflammation
por: Asperti, Michela, et al.
Publicado: (2018)

α‐Synuclein in blood cells differentiates Parkinson’s disease from healthy controls
por: Abd Elhadi, Suaad, et al.
Publicado: (2019)

Hepcidin antagonists for potential treatments of disorders with hepcidin excess
por: Poli, Maura, et al.
Publicado: (2014)

Non-Anticoagulant Heparins Are Hepcidin Antagonists for the Treatment of Anemia
por: Poli, Maura, et al.
Publicado: (2017)

Applications and Properties of Magnetic Nanoparticles
por: Arosio, Paolo
Publicado: (2021)

Iron, Oxidative Damage and Ferroptosis in Rhabdomyosarcoma
por: Fanzani, Alessandro, et al.
Publicado: (2017)

Therapeutic Targets and Personalized Medicine in Cardiac Disease
por: Vafiadaki, Elizabeth, et al.
Publicado: (2023)

Iron Deficiency as a Therapeutic Target in Cardiovascular Disease
por: Lakhal-Littleton, Samira
Publicado: (2019)

Iron as a therapeutic target in chronic liver disease
por: Kouroumalis, Elias, et al.
Publicado: (2023)

Circular RNAs: New Therapeutic Targets for Cardiovascular Diseases
por: Park, Hun-Jun
Publicado: (2022)

Multilevel Impacts of Iron in the Brain: The Cross Talk between Neurophysiological Mechanisms, Cognition, and Social Behavior
por: Ferreira, Ana, et al.
Publicado: (2019)

Special Issue: Nutraceutical Approaches to Cardiovascular and Metabolic Diseases: Evidence and Opportunities
por: Magni, Paolo, et al.
Publicado: (2022)

The mitochondrial calcium uniporter: a new therapeutic target for Parkinson’s disease-related cardiac dysfunctions?
por: Scorza, Fúlvio Alexandre, et al.
Publicado: (2020)

Therapeutic hypothermia in stroke: Quo Vadis?
por: Almekhlafi, Mohammed A., et al.
Publicado: (2019)

The Role of Autophagy in Liver Diseases: Mechanisms and Potential Therapeutic Targets
por: Cursio, Raffaele, et al.
Publicado: (2015)

Mitochondrial Oxidative and Nitrosative Stress as a Therapeutic Target in Diseases
por: Marí, Montserrat, et al.
Publicado: (2021)

BACE1: from biomarker to Alzheimer’s disease therapeutical target
por: Cervellati, Carlo, et al.
Publicado: (2021)

Hypertension and Cardiovascular Diseases: From Etiopathogenesis to Potential Therapeutic Targets
por: Bernatova, Iveta, et al.
Publicado: (2022)

Cardiac Fibrosis: Chronic Inflammatory Disease and Promising Therapeutic Target
por: Okamoto, Ryuji
Publicado: (2022)

High Sulfation and a High Molecular Weight Are Important for Anti-hepcidin Activity of Heparin
por: Asperti, Michela, et al.
Publicado: (2016)

Is VEGF a new therapeutic target for hypertension in chronic kidney disease?
por: Kim, Yon Su
Publicado: (2013)

New Insights into Diabetic Kidney Disease: The Potential Pathogenesis and Therapeutic Targets
por: Liu, Wei Jing, et al.
Publicado: (2017)

COVID-19: New disease mechanism is simultaneously a therapeutic target
por: Schmitt, Clemens A.
Publicado: (2022)

Special Issue “Gut Microbiota, Inflammatory Bowel Diseases, and Therapeutic Targets”
por: Filidou, Eirini, et al.
Publicado: (2023)

Molecular Imaging in Targeted Therapeutics
por: Wang, Yuebing, et al.
Publicado: (2018)

Novel Therapeutic Targets in Melanoma
por: Cerezo, Michaël, et al.
Publicado: (2023)

Novel Therapeutic Targets in Cancers
por: Levantini, Elena
Publicado: (2023)

Therapeutic Targeting of the Proteolytic Enzymes
por: Couture, Frédéric
Publicado: (2022)

Nutrition and Muscle Health
por: Arosio, Beatrice, et al.
Publicado: (2021)

Casting Iron in the Pathogenesis of Fibrotic Lung Disease
por: Brown, Alexandra C., et al.
Publicado: (2021)

Iron Metabolism, Redox Balance and Neurological Diseases
por: Gao, Guofen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dj2mams4o3gejbg71uckp7ks0f